É. Berger

1.8k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

É. Berger is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, É. Berger has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in É. Berger's work include Blood transfusion and management (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (4 papers). É. Berger is often cited by papers focused on Blood transfusion and management (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (4 papers). É. Berger collaborates with scholars based in France, Germany and Austria. É. Berger's co-authors include Martin Rössle, Klaus Haag, Andreas Ochs, W. Gerok, M. Sellinger, Jean–Marc Perarnau, Andreas Gabelmann, Karlheinz Hauenstein, U. Blum and G Nöldge and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

É. Berger

29 papers receiving 1.1k citations

Hit Papers

The Transjugular Intrahepatic Portosystemic Stent-Shunt P... 1994 2026 2004 2015 1994 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding
    1994 567 citations Martin Rössle, Klaus Haag et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
É. Berger France 13 752 688 620 102 96 31 1.2k
Nir Hilzenrat Canada 16 693 0.9× 596 0.9× 214 0.3× 72 0.7× 52 0.5× 56 1.1k
Eun Hwa Kim South Korea 12 119 0.2× 176 0.3× 88 0.1× 58 0.6× 143 1.5× 49 637
Hannelore Barg‐Hock Germany 21 642 0.9× 380 0.6× 485 0.8× 50 0.5× 43 0.4× 43 1.1k
Aytekin Alçelik Türkiye 17 44 0.1× 264 0.4× 143 0.2× 64 0.6× 87 0.9× 55 882
Ruth Topless New Zealand 22 69 0.1× 257 0.4× 341 0.6× 30 0.3× 393 4.1× 44 1.4k
Bernhard Vaske Germany 16 135 0.2× 314 0.5× 303 0.5× 102 1.0× 160 1.7× 61 969
Ji Bong Jeong South Korea 15 87 0.1× 167 0.2× 330 0.5× 153 1.5× 98 1.0× 62 773
Jonathan Wyse Canada 13 41 0.1× 184 0.3× 342 0.6× 134 1.3× 24 0.3× 39 708
Bridget Flynn United States 13 326 0.4× 211 0.3× 501 0.8× 23 0.2× 50 0.5× 21 1.1k
Kinga Karlinger Hungary 16 27 0.0× 213 0.3× 336 0.5× 141 1.4× 103 1.1× 51 868

Countries citing papers authored by É. Berger

Since Specialization
Citations

This map shows the geographic impact of É. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Berger more than expected).

Fields of papers citing papers by É. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Berger. The network helps show where É. Berger may publish in the future.

Co-authorship network of co-authors of É. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of É. Berger. A scholar is included among the top collaborators of É. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Berger. É. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, É., et al.. (2018). Analyse des causes de destruction des produits sanguins labiles dans les établissements de santé : une étude multicentrique. Transfusion Clinique et Biologique. 25(4). 242–248. 2 indexed citations
2.
Berger, É., Shira Anzi, Eitan Shaulian, et al.. (2017). Ras–Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor function. Oncogene. 36(26). 3729–3739. 8 indexed citations
3.
Berger, É., et al.. (2017). Est-ce que la réalisation de la recherche d’anticorps antiérythrocytaires post–transfusionnelle est toujours pertinente ?. Transfusion Clinique et Biologique. 25(1). 8–13. 1 indexed citations
4.
Hoffmann, Markus, Mariana González-Hernández, É. Berger, Andrea Marzi, & Stefan Pöhlmann. (2016). The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent. PLoS ONE. 11(2). e0149651–e0149651. 26 indexed citations
5.
Natarajan‐Amé, Shanti, Sophie Park, Lionel Adès, et al.. (2012). Bortezomib combined with low‐dose cytarabine in Intermediate‐2 and high risk myelodysplastic syndromes. A phase I / II Study by the GFM. British Journal of Haematology. 158(2). 232–237. 12 indexed citations
6.
Berger, É., et al.. (2010). Évaluation multicentrique de la pertinence des prescriptions de concentrés de globules rouges. Transfusion Clinique et Biologique. 17(5-6). 318–330. 10 indexed citations
7.
Berger, É., T-E. Ciuleanu, L. Hart, et al.. (2007). Results of a randomized phase II study of irofulven in hormone-refractory prostate cancer patients that have failed first-line docetaxel treatment. Journal of Clinical Oncology. 25(18_suppl). 5068–5068. 8 indexed citations
8.
Berger, É., et al.. (2006). Leucémies aiguës chez deux patients atteints de sclérose en plaques et traités par mitoxantrone. Revue Neurologique. 162(2). 195–199. 11 indexed citations
9.
Rössle, Martin, Manfred Olschewski, V. Siegerstetter, et al.. (2004). The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery. 135(4). 394–403. 101 indexed citations
10.
Dumontet, Charles, J. Jaubert, Catherine Sebban, et al.. (2003). Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients. Annals of Oncology. 14(4). 615–622. 7 indexed citations
11.
Rössle, Martin, V. Siegerstetter, Manfred Olschewski, et al.. (2001). How much reduction in portal pressure is necessary to prevent variceal rebleeding? a longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. The American Journal of Gastroenterology. 96(12). 3379–3383. 70 indexed citations
12.
Boiardi, A., Antonio Silvani, Emilio Ciusani, et al.. (2001). Fotemustine Combined with Procarbazine in Recurrent Malignant Gliomas: A Phase I Study with Evaluation of Lymphocyte O6-alkylguanine–DNA Alkyltransferase Activity. Journal of Neuro-Oncology. 52(2). 149–156. 13 indexed citations
13.
Haag, K., Martin Rössle, A. Ochs, et al.. (1999). Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension.. American Journal of Roentgenology. 172(3). 631–635. 75 indexed citations
14.
15.
Brandenberger, A. W., et al.. (1998). CA-125 Concentrations in the Serum and Pregnancy Outcome in IVF Cycles. Journal of Assisted Reproduction and Genetics. 15(6). 390–394. 11 indexed citations
16.
Haag, K., A. Ochs, Peter Deibert, et al.. (1994). [Hemodynamics, liver function and clinical follow-up after TIPS].. PubMed. 34(4). 183–6. 1 indexed citations
17.
Rössle, Martin, Klaus Haag, Andreas Ochs, et al.. (1994). The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding. New England Journal of Medicine. 330(3). 165–171. 567 indexed citations breakdown →
18.
Berger, É., et al.. (1992). Influence of age on outcome of mechanically ventilated patients in an intensive care unit. Critical Care Medicine. 20(4). 489–492. 63 indexed citations
19.
Haag, K., et al.. (1985). Determination of rheogenic ion transport in rat proximal colon in vivo. Pflügers Archiv - European Journal of Physiology. 405(S1). S67–S70. 7 indexed citations
20.
Knauf, H., et al.. (1984). Determination of short-circuit current in the in vivo perfused rat colon. American Journal of Physiology-Gastrointestinal and Liver Physiology. 246(2). G151–G158. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nir Hilzenrat Breakdown of academic impact, for papers by Eun Hwa Kim Breakdown of academic impact, for papers by Hannelore Barg‐Hock Breakdown of academic impact, for papers by Aytekin Alçelik Breakdown of academic impact, for papers by Ruth Topless Breakdown of academic impact, for papers by Bernhard Vaske Breakdown of academic impact, for papers by Ji Bong Jeong Breakdown of academic impact, for papers by Jonathan Wyse Breakdown of academic impact, for papers by Bridget Flynn Breakdown of academic impact, for papers by Kinga Karlinger
Rankless by CCL
2026